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Abstract Posttranslational modification is a common
cellular process that is used by cells to ensure a particular
protein function. This can happen in a variety of ways, e.g.,
from the addition of phosphates or sugar residues to a
particular amino acid, ensuring proper protein life cycle
and function. In this review, we assess the evidence for
ubiquitination, glycosylation, phosphorylation, S-nitrosy-
lation as well as other modifications in connexins and
pannexin proteins. Based on the literature, we find that
posttranslational modifications are an important component
of connexin and pannexin regulation.
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Introduction
Posttranslational modification is a common method by
which proteins can be modulated by intrinsic or extrinsic
factors to potentiate or initiate a specific function. It is now
well accepted that these modifications are a key way in
which a protein can become useful in the context of cel-
lular physiology. This is not different when it comes to the
connexin and pannexin family of proteins, where a fairly
broad range of modifications has now been described that
can alter the function of these proteins, from the dramatic
(e.g., opening or closing of the channel/gap junction/
hemichannel) to the subtle (e.g., insertion into specialized
lipid rafts).
Connexin and pannexin proteins are transmembrane
proteins that allow for the passive diffusion of signaling
molecules through their pores. Connexins are the key
components to gap junctions, linking the cytoplasms of two
opposing cells and allowing for rapid electrical or chemical
integration among cells in a tissue. These proteins, when
composed as a gap junction, allow for several functions,
including electrical coordination of cardiac myocytes or
ciliary beat frequency between tracheal epithelium, with
several mutations in connexins associated with disease
states (Boitano and Evans 2000; Johnson and Koval 2009;
Kelsell et al. 2001; Lai et al. 2006; Palatinus and Gourdie
2007). Undocked connexin hemichannels have also been
hypothesized to play a more paracrine role in cellular
communication in more pathological states (De Vuyst et al.
2007; Pearson et al. 2005). While membrane topology is
similar to that of connexins, pannexins share no sequence
homologies with connexins and are a more recently iden-
tified class of transmembrane proteins (Panchin et al.
2000). Pannexins can be found in three different isoforms
(Panx1, Panx2 and Panx3) encoded by three different
genes, with Panx1 and Panx3 sharing more similarities to
each other than to Panx2 (Penuela et al. 2007). In the past
decade, a growing body of literature has revealed that
pannexins play multiple roles as they have been shown to
release ATP and participate in calcium wave propagation
and are likely a component of the inflammasome (Dando
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and Roper 2009; Locovei et al. 2006; Silverman et al.
2009; Sridharan et al. 2010). Thus, both connexins and
pannexins are critical for cells to coordinate direct and
paracrine communication (Fig. 1). In this review, we aim
to bring together data focusing on the roles for glycosyla-
tion, phosphorylation, S-nitrosylation, ubiquitination and
other posttranslational modifications in regulating the
functions of both connexin and pannexin proteins.
Glycosylation
Glycosylation is a form of posttranslational modification
which consists of the enzymatic addition of glycans to form
glycosylated proteins. The enzyme glycosyltransferase cat-
alyzes the attachment of glycans to a nitrogen of asparagine
(N-linked glycosylation) or to a hydroxyl oxygen of threo-
nine or serine (O-linked glycosylation) residues (Freeze and
Sharma 2010; Reis et al. 2010). Glycosylation mostly occurs
in the endoplasmic reticulum (ER) or Golgi apparatus and
can affect protein folding and stability, influence protein
trafficking and interfere with protein function (Pinho et al.
2011; Reis et al. 2010; Roth et al. 2010).
Connexin proteins are not glycosylated despite identi-
fication of the N-glycosylation consensus sequence in Cx32
(Martin and Evans 2004; Rahman et al. 1993; Saez et al.
2003). However, it should be noted that a few reports have
shown that inhibition of protein glycosylation in cells
transfected with Cx43 can increase trafficking of Cx43 to
the plasma membrane, its phosphorylation and its opening
indirectly via a cAMP pathway (Wang and Mehta 1995;
Wang et al. 1995; Wang and Rose 1995).
Currently, the primary identified posttranslational mod-
ification in pannexins is glycosylation. Glycosylation of the
Panx1 isoforms leads to a migration shift on SDS gel with
bands representing three different glycosylation states,
whereas the multiple band pattern of Cx43 has been
demonstrated to represent different phosphorylated states
(Boassa et al. 2007, 2008; Penuela et al. 2007, 2009; Solan
and Lampe 2009). The different glycosylation states of
Panx1 result in a multiple banding pattern on a Western
blot, with the Gly2 species migrating slower than Gly1 as
an intermediate band and the Gly0 species being the fast-
est-migrating form (Boassa et al. 2007, 2008; Penuela et al.
2007, 2009). Of the three pannexin isoforms, Panx1 and
Panx3 have been shown to be glycosylated and their gly-
cosylation sites have been defined, whereas the glycosyl-
ation site of Panx2 has only been predicted (Boassa et al.
2007, 2008; Penuela et al. 2007, 2009, 2012).
Panx1 and Panx3 are N-glycosylated on the amino acids
asparagine (N) 254 and N71, respectively, and can be found
in three different states: a core unglycosylated protein
(Gly0), a high mannose-glycosylated protein (Gly1) and an
extensively glycosylated species (Gly2) (Boassa et al. 2007;
Penuela et al. 2007, 2009). The role of N-glycosylation of
Panx1 was explored using site-directed mutagenesis of
N254 targeted by N-glycosylation (Panx1N254Q) (Boassa
et al. 2007, 2008; Penuela et al. 2007, 2008). Similarly, the
role of Panx3 N-glycosylation was investigated using the
mutant Panx3N71Q (Penuela et al. 2007, 2008). These gly-
cosylation mutants exhibit reduced trafficking to the plasma
membrane when transfected in different cell lines, sug-
gesting an important role for N-glycosylation in Panx1 and
Panx3 trafficking (Boassa et al. 2007, 2008; Penuela et al.
2007, 2008). However, despite the low amount of
Panx1N254Q and Panx3N71Q at the plasma membrane, the
mutated proteins still form channels, as evidenced by dye
uptake measurements (Penuela et al. 2007, 2009). Addi-
tionally, when wild-type Panx1 and Panx1N254Q are
cotransfected, the trafficking of the glycosylation mutant to
the plasma membrane is rescued, showing that they co-
oligomerize and suggesting that N-glycosylation does not
play a role in oligomerization of Panx1 (Boassa et al. 2008).
Altogether, these studies demonstrate that the Gly0 species
appears primarily after protein synthesis, whereas Gly1 is
associated within the ER and Gly2 is modified in the Golgi
apparatus prior to plasma membrane insertion. However, it
should be noted that all Panx1 glycosylated species are
capable of trafficking to the plasma membrane but the Gly2
form is preferentially trafficked (Gehi et al. 2011).
Phosphorylation
Posttranslational modification through phosphorylation
acts as a major regulatory pathway in normal protein life
Fig. 1 Schematic list of posttranslational modifications throughout
the life span of connexins and pannexins. Numbers are the amino
acids in the proteins as indicated in the references. Note that only
when amino acids or specific regions on the protein could be
identified were they included in the figure; e.g., although palmitoy-
lation has been indicated for Panx2 (Swayne et al. 2010), the exact
region on the protein remains unknown. *Shown indirectly through
PKA; #this cysteine is assumed to be S-nitrosylated in a hemichannel
(based on Retamal et al. 2006) but has not been directly shown; ?data
are now in dispute according to Dunn et al. (2012). 1 Paulson et al.
(2000), TenBroek et al. (2001); 2 Locke et al. (2006); 3 Cooper and
Lampe (2002); 4 Cottrell et al. (2003), Kanemitsu et al. (1998),
Lampe et al. (1998), Norris et al. (2008), Warn-Cramer et al. (1998);
5 Doble et al. (2004), Ek-Vitorin et al. (2006), Lampe et al. (2000); 6
Solan and Lampe (2008); 7 Straub et al. (2011); 8 Kjenseth et al.
(2012); 9 Bao et al. (2004b, 2007); 10 Toyofuku et al. (2001); 11
Lampe et al. (2000), Solan et al. (2003); 12 Kanemitsu et al. (1998),
Lampe et al. (1998), Xie et al. (1997); 13 Beardslee et al. (2000),
Solan et al. (2007); 14 Hertlein et al. (1998); 15 Yin et al. (2001), Yin
et al. (2008); 16 Wagner et al. (2011); 17 Boassa et al. (2007),
Penuela et al. (2007); 18 Penuela et al. (2007); 19 Chekeni et al.
(2010); 20 Kim et al. (2011)
c
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cycles and can be further affected in pathological states by
upregulation of kinase pathways. These pathways regulate
protein functions through addition of a phosphate group by
kinases to serine (S), threonine (T) and tyrosine (Y) sites,
which may lead to alterations in the hydrophobicity, charge
and potentially structural reorganization of proteins, either
promoting or inhibiting normal functions (Davis 2011;
Huttlin et al. 2010; Nishi et al. 2011).
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Phosphorylation of connexins has been extensively
demonstrated and reviewed (particularly for Cx43) and is
integral in their life cycle–altering protein oligomerization,
trafficking, membrane insertion and aggregation, gap
junction communication and internalization from the
membrane (Laird 2005; Laird et al. 1995; Marquez-Rosado
et al. 2011; Saez et al. 1990, 1998; Solan and Lampe 2005,
2009). Phosphorylation has been demonstrated for multiple
S/T/Y sites through c- and v-SRC; mitogen-activated pro-
tein kinase (MAPK), protein kinase C (PKC), protein
kinase A (PKA), P34cdc (CDC2), casein kinase 1 (CK1)
and calmodulin-dependant protein kinase pathways
(Lampe and Lau 2004; Saez et al. 1998; Solan and Lampe
2005, 2009).
Posttranslational modification through phosphorylation
of cytoplasmic residues primarily occurs within the conn-
exin carboxyl terminus. Additionally, phosphorylation sites
in the Cx43 amino terminus (S5) and the Cx56 intracellular
loop have been identified as phosphorylated (Berthoud
et al. 1997; Chen et al. 2012; Wisniewski et al. 2010). Cx43
does not contain serines within its intracellular loop and is
therefore not modified directly by phosphorylation within
this region (Solan and Lampe 2005). As a result of a short
19-amino acid carboxyl terminus containing only two
serines, Cx26 is the only isoform that is currently consid-
ered not to be posttranslationally modified through phos-
phorylation (Traub et al. 1989). Conversely, Cx43 contains
a total of 66 S/T/Y sites (32 in the carboxyl terminus) and
has been demonstrated to be highly regulated through
phosphorylation primarily at serine residues (Chen et al.
2012; Crow et al. 1990; Marquez-Rosado et al. 2011).
Phosphoproteomic analyses used to determine the inci-
dence of protein phosphorylation in vitro and across mul-
tiple tissues, ranging from brain, kidney, lung, spleen and
more, derived from mice, rats and humans have demon-
strated that Cx43 as well as Cx47, Cx32 and Cx29 are
phosphorylated at multiple sites at their carboxyl terminus
as well as the amino terminus (Brill et al. 2009; Cooper
et al. 2000; Huttlin et al. 2010; Rikova et al. 2007; Wis-
niewski et al. 2010). These studies and others further
suggest that connexins are regulated by complex multisite
phosphorylation, which plays an important role in the rapid
generation and turnover of connexin proteins in a multitude
of tissues and organ systems (Chen et al. 2012; Johnson
and Vaillancourt 1994). This area of study will become
increasingly important in terms of understanding how
multiple phosphorylation events can ‘‘tip the balance’’ one
way or another toward a particular protein function.
Connexins are posttranslationally oligomerized to hex-
americ hemichannels prior to membrane insertion either
within the ER (e.g., Cx26, Cx32) (Falk et al. 1997; Falk
and Gilula 1998) or in the trans-Golgi network (e.g., Cx43,
Cx46) (Das Sarma et al. 2001; del Castillo et al. 2009;
Koval 2006; Koval et al. 1997; Musil and Goodenough
1993; Puranam et al. 1993). A role for connexin phos-
phorylation in channel oligomerization has not currently
been demonstrated (Solan and Lampe 2005). Pulse-chase
studies have shown that newly synthesized Cx43 can be
rapidly phosphorylated and dephosphorylated (within
15–30 min) (Crow et al. 1990) in the ER and Golgi com-
partments (Laird et al. 1995). In addition, monomeric Cx43
phosphoisoforms have been identified, which suggests that
Cx43 is phosphorylated prior to insertion into the plasma
membrane (Musil and Goodenough 1993). Further,
increases in PKA activity can promote Cx43 integration to
the membrane and are associated with Cx43-S364 phos-
phorylation, but Cx43 is a poor substrate for PKA and does
not appear to directly increase Cx43 phosphorylation,
suggesting that other intermediary pathways mediate the
response (Paulson et al. 2000; TenBroek et al. 2001). Data
demonstrating nonphosphorylated isoforms of connexins at
the membrane suggest that they can be inserted to the
membrane without phosphorylation (although transient
phosphorylations could occur prior to entry to the mem-
brane (Musil et al. 1990; Musil and Goodenough 1991;
Solan and Lampe 2005). This is also evident with truncated
mutations of Cx43 (D252) oligomerizing and trafficking to
the plasma membrane. These truncated channels still form
functional channels, suggesting that phosphorylation on the
carboxyl tail is not a critical requirement (Johnstone et al.
2009; Martinez et al. 2003). Regardless, deletion muta-
genesis studies have demonstrated that a portion of the
Cx43 carboxyl terminus is required for trafficking. By
creating a carboxyl terminus deletion at amino acid 236,
Cx43 cannot traffic to the membrane, while deletions after
amino acid 239 (D243/D239) traffic to the membrane and
form gap junctions (De Vuyst et al. 2007; Wayakanon et al.
2012). As with Cx43, Cx45 requires its carboxyl terminus
to target the membrane. Phosphorylation does not signifi-
cantly alter Cx45 trafficking to the membrane but may
affect protein half-life (Hertlein et al. 1998). Current data
therefore suggest that phosphorylation of connexins is not a
critical determinant of oligomerization and membrane
insertion but could be involved in efficient gap junction
assembly and trafficking.
The open and closed states of connexin hemichannels
exist as a balance between inhibition and stimulation of
carboxyl terminal residues. Mutagenesis studies of Cx43
have shown that mutations after amino acid 239 in Cx43
can still form functional gap junctions but inhibit hemi-
channel opening, suggesting that regulatory sites within the
carboxyl terminus are required for hemichannel opening
(De Vuyst et al. 2007). In general, connexin phosphoryla-
tion through PKC (e.g., S368) and MAPK activity main-
tains a closed hemichannel state (Bao et al. 2004a, 2007;
Chandrasekhar and Bera 2012; Contreras et al. 2002;
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Ek-Vitorin et al. 2006; Kwak and Jongsma 1996; Schulz
and Heusch 2004; Srisakuldee et al. 2009). Indeed, it has
been shown that direct phosphorylation of Cx43-S368 by
PKC reduces hemichannel opening (Bao et al. 2004b).
Similarly, treatments with lipopolysaccharide and basic
fibroblast growth factor decrease hemichannel activity in
Cx32-, Cx43- and Cx26-expressing HeLa cells (De Vuyst
et al. 2007). However, the same treatments enhance
hemichannel opening in C6-Cx43 cells (De Vuyst et al.
2007). This diversity in hemichannel signaling has been
attributed to a balance between channel inhibition (phos-
phorylation) and stimulation (dephosphorylation) modifi-
cations on the connexin carboxyl terminus (Contreras et al.
2002; De Vuyst et al. 2007).
As described above, the carboxyl terminus of connexins
(particularly Cx43) may act to promote efficient gap
junction assembly from hemichannels. Once inserted to the
membrane, hemichannels aggregate in ‘‘formation pla-
ques’’ prior to incorporation into the gap junctional plaque
(Johnson et al. 2012; Segretain and Falk 2004). Truncation
mutants of Cx43 result in reduced hemichannel aggrega-
tion and gap junction plaque formation, suggesting that
phosphorylation of carboxyl-terminal residues may be
involved in efficient delivery of hemichannels to the gap
junction plaque (Johnson et al. 2012; Palatinus et al.
2011a). Increased formation and stability of gap junctions
have been associated with PKA and CK1 activity. Increa-
ses in intracellular cAMP levels promote PKA activity,
which promotes (indirectly) Cx43-S364 phosphorylation
and increases in gap junction assembly and coupling
(TenBroek et al. 2001). CK1 phosphorylation of Cx43-
S325/S328/S330 also appears to promote gap junction
assembly and stability (Cooper and Lampe 2002). Gap
junction aggregation occurs through directed trafficking by
chaperone proteins, e.g., zonula occludens-1/2 (ZO-1/ZO-
2) (Rhett et al. 2011; Singh et al. 2005). Associations
between the Cx43 carboxyl terminus and ZO-1 promote
targeting to gap junction plaques (Hunter et al. 2005; Jin
et al. 2004; Segretain et al. 2004; Toyofuku et al. 1998).
This can be disrupted through c-SRC phosphorylation of
Cx43-Y265, which appears to be a critical site in the
binding of ZO-1 (Toyofuku et al. 2001). Therefore, phos-
phorylation may allow for efficient and directed movement
of connexins within the membrane to sites of gap junction
plaques.
In general, for Cx43, CK1 (and PKA) pathways increase
and PKC, MAPK, v-SRC, and CDC2 reduce gap junctional
communication (Pahujaa et al. 2007; Solan and Lampe
2005, 2008, 2009). Phosphorylation-induced increases in
gap junctional communication occur through CK1 phos-
phorylation of Cx43-S325/S328/S330 (Cooper and Lampe
2002) and by PKA (Cx43-S364, indirectly) (TenBroek
et al. 2001). However, as mentioned, these sites are also
associated with increased gap junction assembly; and it has
been suggested that they may enhance plaque stability,
leading to a prolonged life cycle (Remo et al. 2011). In
addition, phosphorylation of Cx40 by PKA pathways leads
to altered (higher) conductance states (van Rijen et al.
2000).
PKC activity reduces Cx43 gap junctional communica-
tion. Reduced unitary conductance occurs following Cx43-
S368 phosphorylation (Ek-Vitorin et al. 2006; Lampe et al.
2000), and site-directed mutagenesis demonstrates that
Cx43-S262 phosphorylation can reduce gap junctional
communication, which in turn may act to promote DNA
synthesis and cell cycle progression (Doble et al. 2004).
The impact of reduced communication through PKC
phosphorylation of Cx43-S368 ranges from promoting
wound closure (potentially by isolating cells from sur-
rounding signals and promoting differentiation) (Richards
et al. 2004), causing decreased cell-to-cell communication
in the vascular wall (Straub et al. 2009) and reducing
ischemia–reperfusion injury in hearts (Palatinus et al.
2011b). MAPK phosphorylation of Cx43-S255/S279/S282
leads to reductions in gap junctional communication by
inhibiting the ability of the channels to open (Cottrell et al.
2003; Warn-Cramer et al. 1998). It should also be noted
that several sites in the Cx43 tail may be phosphorylated
through multiple pathways as is demonstrated for PKC
induction by phorbol 12-myristate 13-acetate, which pro-
motes Cx43 S279/S282 phosphorylation (Solan and Lampe
2007, 2009). In addition to the classically accepted MAPK
sites, Norris et al. (2008) demonstrated that Cx43-S262
sites were phosphorylated (but not S368) through MAPK
pathways, leading to reduced gap junctional communica-
tion and meiotic resumption in mouse oocytes. Increases in
CDC2 promote phosphorylation of Cx43-S255 and reduc-
tions in gap junctional communication, which are associ-
ated with progression through the cell cycle (Kanemitsu
et al. 1998; Lampe et al. 1998). Activation of v-SRC
pathways leads to phosphorylation of Cx43-Y247 and
Cx43-Y265, which appears to occur in formed gap junc-
tions, leading to a reduction in gap junctional communi-
cation (Solan and Lampe 2008). In addition to these sites,
active v-SRC can cause phosphorylation at sites associated
with PKC and MAPK in Cx43 (Solan and Lampe 2008).
Less is known for the other connexins. Sequence pre-
dictions and homology suggest that Cx37 may be similarly
phosphorylated through MAPK pathways, potentially at
Cx37-S275 and Cx37-S282, which may affect gap junc-
tional assembly and communication; but this has not been
directly demonstrated (Burt et al. 2008). Phosphorylation
of Cx45 through PKC pathways alters the occupancy time
and conductive state of the channel (Kwak et al. 1995; van
Veen et al. 2000). Although Cx45 is primarily phosphor-
ylated at serines, substitution of all carboxyl-terminus
S. R. Johnstone et al.: Connexin and Pannexin Modifications 323
123
serines does not alter gap junctional communication in
HeLa cells (Hertlein et al. 1998).
Phosphorylation also plays a role in the internalization
of connexins from the gap junctional plaque and has been
shown to alter the protein turnover rates for several
connexins (Laird 2005). During the cell cycle Cx43
appears to be dynamically regulated at the S, G1, G2 and
M phases, all represented by alterations in Cx43 phos-
phorylation and internalization. As the cell cycle pro-
gresses, Cx43 appears at more intracellular locations and
is highly phosphorylated at CDC2, PKC and MAPK sites,
suggesting that phosphorylation may be involved in the
removal of the connexins from the membrane gap junc-
tion plaques. However, it has not been conclusively
demonstrated whether this results from removal of con-
nexins from gap junction plaques or from reduced
assembly to plaques (Solan and Lampe 2009). In mitosis,
phosphorylation of Cx43 by CDC2 at the S255 and S262
regions is associated with an internalization of the protein
(Kanemitsu et al. 1998; Lampe et al. 1998; Xie et al.
1997). During the cell cycle Cx43-S368 phosphorylation
is also associated with a reduction in gap junction plaque
size and protein internalization (Lampe et al. 2000; Solan
et al. 2003). Conversely, it has been noted that dephos-
phorylation of Cx43 (S365) promotes an intracellular
redistribution of Cx43 (Beardslee et al. 2000; Solan et al.
2007) or removal of Cx43 plaques (Laird et al. 1995).
Substitution of Cx45-S381/S382/S384/S385 residues, but
not the remaining serines from the carboxyl terminus of
Cx45, significantly reduces the protein half-life by
approximately 50 %, suggesting that these sites are
involved in protein degradation (Hertlein et al. 1998).
More recently, the MAPK phosphorylation of Cx43 at
S255/262/279/282 was identified as critical to binding
with cyclin E and promotion through the cell cycle
(Johnstone et al. 2012).
While phosphorylation of connexins is integral to their
functionality, much less has been demonstrated for mod-
ulation of pannexin channels. Despite this, all mammalian
forms of pannexins contain multiple S/T/Y sites (Penuela
et al. 2007). Currently, there are limited structural data for
the pannexins and their carboxyl-terminus regions (Amb-
rosi et al. 2010). The membrane topology of pannexins
appears to resemble that of the connexins with a cyto-
plasmic amino terminus, intracellular loop and carboxyl
terminus, which shows the greatest sequence variability in
the Panx2 isoform (Penuela et al. 2012). As with the
connexins, the carboxyl-terminus regions are rich in S/T/Y
sites. Consensus sequences for S/Y/T phosphorylation have
been predicted based on sequence and membrane topology
for pannexins 1–3 to occur primarily in the carboxyl ter-
minus with fewer intracellular loop motifs (Barbe et al.
2006; Penuela et al. 2007). It has been shown that Panx1
ATP release can be induced by P2X7R activation through
tyrosine kinase pathways, but it is not clear whether Panx1
is directly phosphorylated or regulated through intermedi-
ary pathways (Iglesias et al. 2009). While data on phos-
phorylation of pannexins are currently in their infancy,
there is clearly the potential for this posttranslational
modification in the regulation of the protein life cycle or
function.
Nitrosylation
Posttranslational modification can also occur through S-
nitrosylation, in which nitric oxide (NO) can bind to a
reactive cysteine (C) thiol, producing an S-nitrosothiol
(SNO) (Stamler et al. 1992). While proteins often contain
multiple cysteine residues, the majority of the observed
biological effects imparted by NO occur on single or only a
few cysteine residues within a protein. In addition to direct
modification of proteins by S-nitrosylation, this posttrans-
lational modification can indirectly regulate other protein
modifications including acetylation, phosphorylation and
ubiquitination (Hess and Stamler 2012; Park et al. 2004;
Whalen et al. 2007; Yasukawa et al. 2005).
The effects of NO on hemichannels and gap junctions
have primarily been investigated in vascular cell types
including vascular endothelial and smooth muscle cells. Of
particular note, it was initially shown that exogenous
application of the NO donor S-nitroso-N-acetylpenicilla-
mine to cultured human umbilical vein endothelial cells
significantly decreased dye transfer between coupled cells in
a Cx37-dependent manner (Kameritsch et al. 2005). The
observed decrease in gap junction permeability was inde-
pendent of the effects of NO on guanylate cyclase and cGMP
levels, indicating a separate effect of NO on the channels. In
a separate study, NO application significantly reduced
electrical coupling between cultured human microvascular
endothelial cells mediated by effects on gap junctions
composed of Cx37, which was similarly independent of
cGMP (McKinnon et al. 2009). Conducted vasoconstriction
in cremasteric arterioles has been shown to be dependent on
Cx37 gap junctions and, importantly, is impaired during
sepsis, a pathology resulting in upregulation of nNOS and
increased NO production (McKinnon et al. 2006).
While S-nitrosylation of gap junctions composed of
Cx37 has not been directly observed, evidence has indi-
cated the ability of Cx43 to be S-nitrosylated; and this
modification has been suggested to regulate gap junction
permeability at the myoendothelial junction (MEJ) in the
blood vessel wall (Straub et al. 2011). In this study, Cx43
was found to be locally enriched along with eNOS at the
MEJ. Importantly, Cx43 was constitutively S-nitrosylated
at C271. The S-nitrosylation of C271 on Cx43 was directly
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correlated with an open channel probability as denitrosy-
lation significantly reduced heterocellular communication
at the MEJ, namely, the movement of inositol triphosphate
from smooth muscle cells to endothelial cells through Cx43
gap junctions. In agreement, pharmacological inhibition or
genetic depletion of the denitrosylase GSNOR, which
indirectly affects the extent of S-nitrosylation in these cells
by reducing denitrosylation of the NO donor S-nitroso-
gluathione (GSNO), significantly increased gap junctional
communication at the MEJ. Altogether this study suggests
the potential for connexin proteins to become S-nitrosy-
lated at specific cysteine residues, with the modification
affecting channel permeability.
S-nitrosylation has also been proposed to regulate the
permeability of undocked Cx43 hemichannels at the plasma
membrane. During prolonged periods of ischemia or
hypoxia, oxygen deprivation induces the opening of Cx43
hemichannels in cortical astrocytes and cardiomyocytes,
leading to cell death (Contreras et al. 2002; John et al. 1999;
Kondo et al. 2000). The mechanisms regulating Cx43
hemichannel permeability under these conditions have been
suggested to involve dephosphorylation of Cx43 hemi-
channels (a known stimulus for hemichannel activation (Bao
et al. 2004b; Kim et al. 1999) or oxidative modification due
to increased production of reactive oxygen species, includ-
ing NO. A novel study by Retamal et al. (2006) found that
metabolic inhibition of cortical astrocytes resulted in both
dephosphorylation of Cx43 hemichannels as well as an
increase in S-nitrosylation, ultimately leading to an increase
in cellular permeability as determined by dye uptake.
Interestingly, application of reducing agents to these cells
did not affect Cx43 phosphorylation but significantly
reduced both cell permeability and Cx43 S-nitrosylation. In
agreement with this, application of exogenous NO donors
results in increased cell permeability. Together, these
observations indicate a functional role for Cx43 S-nitrosy-
lation in regulating hemichannel permeability at the plasma
membrane of astrocytes.
The potential regulation of hemichannels composed of
Cx46 by NO has also been suggested. When expressed in
Xenopus oocytes, Cx46 hemichannels exhibited increased
voltage sensitivity and current amplitude upon application
of GSNO, as assessed by patch-clamp electrophysiology
(Retamal et al. 2009). Treatment of these cells with the
reducing agent dithiothreitol (DTT) reversed the effects of
GSNO on hemichannel currents, and mutation of the two
endogenous carboxyl-terminus cysteine residues inhibited
the effect of GSNO application. These observations sug-
gest that critical cysteine residues in the carboxyl terminus
of Cx46, like C271 in Cx43, may be modified by S-nitro-
sylation to regulate channel permeability.
Of the three pannexin isoforms characterized to date,
Panx1 is the most widely expressed and is highly expressed
in vascular smooth muscle and endothelial cells in the
arterial vasculature (Billaud et al. 2011; Godecke et al.
2012; Lohman et al. 2012) and in multiple cell types in the
central and peripheral nervous systems (Ray et al. 2005;
Vogt et al. 2005; Xia et al. 2012). Importantly, all these
tissues have enriched NOS expression and actively utilize
NO for signaling. As Panx1 contains multiple cysteine
residues and has been shown to be expressed in tissues with
enhanced NO production, it is possible that Panx1 channels
in these cells may be regulated posttranslationally by S-
nitrosylation. Further, it has been shown that mutation of
C346 in the carboxyl terminus of Panx1 results in a con-
stitutively leaky channel (Bunse et al. 2010). Also, muta-
tion of C40 in the pore-lining region of the first
transmembrane domain of Panx1 produces a constitutively
open channel (Bunse et al. 2011). These results indicate the
importance of Panx1 cysteine residues in regulating chan-
nel gating and permeability. While there are currently no
published reports indicating direct modulation of Panx1
channels by S-nitrosylation, studies have indicated a role
for Panx1 (as well as Panx2) channels in ischemia-induced
neuronal cell death, a condition in which NO production is
markedly enhanced (Bargiotas et al. 2011). Similarly,
oxygen glucose deprivation and metabolic inhibition,
conditions similar to ischemia, both induced excessive NO
production and neuronal cell death mediated by opening of
Panx channels, which was attenuated by pharmacological
blockade of nNOS or reduction of oxidized cysteine thiols
with the reducing agent DTT (Zhang et al. 2008). Impor-
tantly, inhibition of guanylate cyclase in these experiments
had little effect on Panx channel permeability, suggesting
potential effects of NO by S-nitrosylation of Panx channels
in these cells. Future studies will be essential to directly
evaluate the potential for pannexin proteins to be post-
translationally modified by S-nitrosylation and how modi-
fication of Panx channels in this manner affects channel
gating and permeability.
Ubiquitination
The ubiquitin proteasome system regulates the degradation
of many proteins. This can occur at the absolute N-terminal
primary amine of proteins to induce autophagy (e.g., Lich-
tenstein et al. 2011). Although this is a relatively new area of
connexin research, it could be quite important in multiple
disease states. More traditional ubiquitination is comprised
of several components, including E1 ubiquitin-activating
enzymes, E2 ubiquitin-conjugating enzymes and E3 ubiq-
uitin ligases, that together mediate the transfer of the
76-amino acid protein ubiquitin to specific lysine (K) resi-
dues on target proteins (Leithe and Rivedal 2007; Willis
et al. 2010). Multiple ubiquitins can be covalently linked via
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K48 to form polyubiquitin chains, which target the ubiqui-
tinated protein for degradation by the multisubunit 26S
proteasome (Leithe and Rivedal 2007; Voges et al. 1999;
Willis et al. 2010). Both connexins and pannexins have
multiple lysine residues to which ubiquitin may be conju-
gated. Connexins can be ubiquitinated on K9 and K303
(Wagner et al. 2011), while pannexins can have ubiquitin
conjugated to K409 (Kim et al. 2011). Thus, the possible
ubiquitination of connexins and pannexins implies that these
proteins may be regulated by proteasomal degradation.
Several studies have suggested that connexins and
pannexins are ubiquitinated and degraded by the protea-
some. The proteasomal inhibitor N-acetyl-L-leucyl-L-leu-
cinyl-norleucinal increased levels of Cx43 (Laing and
Beyer 1995) and Cx31 (He et al. 2005) and prolonged
Cx43 half-life. Furthermore, immunoprecipitation with
antibodies against Cx43 and ubiquitin suggested that Cx43
might be polyubiquitinated (Laing and Beyer 1995), indi-
cating that disrupting the ubiquitin proteasome system
could alter connexin turnover. The tumorigenic compound
phorbol ester 12-O-tetradecanoylphorbol 13-acetate initi-
ated hyperphosphorylation and ubiquitin-mediated degra-
dation of Cx43, which was prevented by proteasomal
inhibitors (Leithe and Rivedal 2004), demonstrating the
importance of phosphorylation in ubiquitin-mediated
connexin degradation. Phosphorylation of connexins
facilitates interaction with proteins of the ubiquitin pro-
teasome system, such as the ubiquitin ligase Nedd4 (Ley-
kauf et al. 2006). Disrupting the interaction between
connexins and ubiquitin proteasome proteins via prote-
asomal inhibitors alters the interaction between Cx43 and
ZO-1, leading to Cx43 accumulation into enlarged gap
junctions at plasma membranes (Girao and Pereira 2007).
Therefore, it has been suggested that the ubiquitin protea-
some system most likely contributes to the internalization
and degradation of connexins.
Despite these findings, there is mounting evidence
against ubiquitination and proteasomal degradation of
connexins. Degradation of ER-localized Cx43 by the pro-
teasome is partly controlled by Cx43 interactions with the
ubiquitin-like protein CIP75, which binds to ubiquitinated
substrates. However, immunoprecipitation studies demon-
strated that the CIP75-bound Cx43 was not directly ubiq-
uitinated (Su et al. 2010). In addition, a mutant Cx43
construct in which all lysine residues were converted to
arginines mimicked the response of wild-type Cx43 to
proteasomal inhibitors (Dunn et al. 2012). Taken together,
these results indicate that direct ubiquitination may not be
required for proteasomal degradation of Cx43. Instead,
ubiquitination of connexins may contribute to other path-
ways regulating turnover. Indeed, recent studies have
linked Cx43 monoubiquitination to lysosomal degradation.
Following internalization from the plasma membrane,
Cx43 can associate with the ubiquitin-binding proteins Hrs
(hepatocyte growth factor–regulated tyrosine kinase sub-
strate) and Tsg101 (tumor susceptibility gene 101) and the
ubiquitin-binding endocytic adaptor protein Eps15, which
shuttle Cx43 along the endocytic pathway for subsequent
degradation in lysosomal compartments (Girao et al. 2009;
Leithe et al. 2009). Thus, although ubiquitination mediates
connexin trafficking and other degradative pathways, it is
not clear whether direct ubiquitination is an important step
during proteasomal degradation. Connexin turnover by this
pathway most likely involves interaction between ubiqui-
tinated substrates, even if connexins themselves are not
tagged with ubiquitin.
Perturbation of connexin degradation by the ubiquitin
proteasome has physiological and pathological consequences.
Connexins are dynamically regulated with a short half-life of
1–6 h (He et al. 2005; Leithe and Rivedal 2004; Musil et al.
2000; Su et al. 2010). Proper connexin turnover rate is vital to
maintain normal physiological functions (Li and Wang 2010).
Dysregulation of dynamic gap junction protein turnover via
inhibition of the ubiquitin proteasome degradation pathway
(e.g., from oxidative stress) increases gap junction plaque size
and enhances gap junction communication (Girao and Pereira
2007). Inhibition of proteasome-mediated degradation of gap
junction proteins and enhanced gap junction communication
is associated with several cardiovascular pathologies, such as
ischemia–reperfusion injury, cardiac proteinopathy (i.e.,
irregular protein aggregation), post-myocardial infarct
arrhythmias and heart failure (Beardslee et al. 1998; Li and
Wang 2010). Thus, the ubiquitin proteasome pathway may
provide novel therapeutic targets to treat cardiovascular dis-
eases by restoring proper turnover of cardiac proteins,
including connexins.
Much less is known about the involvement of the
ubiquitin proteasome system in pannexin degradation.
Mass spectrometric screens have identified K409 as a
probable site of ubiquitination (Kim et al. 2011). However,
biochemical evidence for pannexin ubiquitination and
proteasomal degradation is lacking. A recent study has
shown that Panx1 internalization and lysosomal degrada-
tion are controlled by its carboxyl-terminus region, but
Panx1 does not appear to be degraded by traditional
endocytic pathways (Gehi et al. 2011). Thus, further
studies are needed to investigate the role ubiquitination
plays in pannexin turnover (Schalper et al. 2012).
Other Modifications
SUMOylation
It has now been demonstrated that connexins (i.e., Cx43)
can be targeted for posttranslation modification by less
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characterized pathways, e.g., SUMOylation. The small
ubiquitin-like modifier (SUMO) family of proteins acts in
most cellular compartments to adapt proteins in multiple
processes including transcription, translation, cellular
transport, protein interactions, cell growth and pro-
grammed cell death (Geiss-Friedlander and Melchior
2007). In Cx43, L144 (intracellular loop) and L237 (car-
boxyl terminus) can be SUMOylated, leading to a reduc-
tion in protein expression and gap junction formation
(Kjenseth et al. 2012). Consensus motifs for SUMOylation
have been identified in the Panx2 sequence; however,
studies of immunoprecipitated Panx2 from mouse neuronal
stem cells differentiated to neurospheres showed a lack of
detection of SUMO1/2/3, suggesting that Panx2 is not
SUMOylated (Swayne et al. 2010). Given the diversity of
activity of SUMO proteins, this posttranslational modifi-
cation could potentially play a significant role in connexins
and pannexin protein regulation and channel formation.
Lipid Modification, e.g., Palmitoylation
The correct insertion of transmembrane proteins into the
plasma membrane is a delicate process that involves the
coordination of protein modifications for the binding of
specific phospholipids (termed ‘‘palmitoylation’’). It has
been well described that connexins are associated with lipid
rafts, especially those enriched with caveoli (e.g., Langlois
et al. 2008; Locke et al. 2005). However, only the carboxyl
terminus of Cx32 (amino acids 277–283) has been identi-
fied to have a palmitoylation site (Locke et al. 2006).
Regardless, this concept was further elucidated by a series
of experiments designed to identify all the phospholipids
that could be associated with either Cx26 or Cx32 gap
junctions. The authors found that the lipids associated with
the two homotypic gap junctions were dramatically differ-
ent, indicating these connexins may reside in very distinct
parts of the plasma membrane (Locke and Harris 2009),
possibly placed there by palmitoylation modifications.
Thus far, there is no indication that pannexin isoforms
associate with caveolin (Gehi et al. 2011). However, it has
been demonstrated that Panx2 has distinct depalmitoylated
and palmitoylated species that migrate at different molec-
ular weights (*60 and *85 kDa, respectively) as deter-
mined by treatment of Western blots with hydroxylamine
or metabolically labeling cells with BODIPY FL hexa-
decanoic acid. Swayne et al. (2010) further suggested that
the palmitoylated form of Panx2 resides in the Golgi and/or
ER, whereas the depalmitoylated form resides primarily at
the plasma membrane and indicates these changes are
associated with differentiation of neuronal cells. Elucida-
tion of the exact site where Panx2 may be palmitoylated
could prove quite interesting.
Caspase Cleavage
The posttranslational modification of proteins is generally
considered to be a reversible process. However, a new type
of terminal posttranslational modification was recently
described where the Panx1 protein was cleaved by caspase
3 during apoptosis, inducing a constitutive open state of the
channel for the release of ATP (Chekeni et al. 2010; Dunn
et al. 2012). The caspase 3 cleavage site was identified in
human Panx1 at amino acids 376–379 (DVVD) (Chekeni
et al. 2010). The implications from the work were that the
carboxyl terminus of Panx1 could regulate the pore open or
closed state. This concept was recently demonstrated in a
novel experimental model (Sandilos et al. 2012). In this
work the authors inserted a TEV sequence into the Panx1
caspase cleavage site, allowing for controlled enzymatic
cleavage of the carboxyl terminus. Next, a disulfide bond
between the carboxyl terminus (C426) and an engineered
cysteine within the pore of the Panx1 channel prevented
removal of the carboxyl terminus from the pore (Sandilos
et al. 2012). Finally, cleavage of the carboxyl terminus by
TEV protease failed to produce current, and only after
disulfide bond removal was current through the Panx1
channel restored (Sandilos et al. 2012). When summed
with the caspase cleavage, the data indicate a role for the
carboxyl terminus in regulating an open or closed pore and
that cleavage of the carboxyl terminus as the specific cas-
pase cleavage site induces a constitutive open channel
during apoptosis. Although multiple connexins have been
implicated throughout the apoptotic pathway (e.g., And-
rade-Rozental et al. 2000; Minogue et al. 2009; Seul et al.
2004), there are no direct links or functional results like
that described for the action of caspase 3 on Panx1.
Conclusion
Although much has been learned about how posttransla-
tional modifications can have dramatic or subtle effects on
connexin and pannexin function, most of these discoveries
have happened only in the last decade. The creation of
more specific antibodies toward modified amino acids (e.g.,
Solan and Lampe 2008) and accessibility of proteomic
arrays to more researchers will enable an even greater
study of posttranslational modifications associated with
connexins and pannexins and their functional effect.
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